Healthcare provider profile · identity verified

Cameron Money Macchia

Nurse Practitioner · PONTE VEDRA BEACH, FL · NPI 1982309985

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	274	56
Levothyroxine Sodium	Levothyroxine Sodium	274	43
Quetiapine Fumarate	Quetiapine Fumarate	228	42
Amlodipine Besylate	Amlodipine Besylate	216	43
Potassium Chloride	Potassium Chloride	200	35
Pantoprazole Sodium	Pantoprazole Sodium	174	38
Eliquis	Apixaban	158	30
Donepezil Hcl	Donepezil Hcl	144	24
Gabapentin	Gabapentin	135	37
Metoprolol Succinate	Metoprolol Succinate	126	25
Tamsulosin Hcl	Tamsulosin Hcl	125	21
Metoprolol Tartrate	Metoprolol Tartrate	119	19
Famotidine	Famotidine	116	23
Torsemide	Torsemide	116	22
Citalopram Hbr	Citalopram Hydrobromide	115	20
Mirtazapine	Mirtazapine	107	23
Metformin Hcl	Metformin Hcl	104	15
Lisinopril	Lisinopril	100	20
Furosemide	Furosemide	96	33
Losartan Potassium	Losartan Potassium	90	17
Trazodone Hcl	Trazodone Hcl	85	23
Simvastatin	Simvastatin	83	18
Memantine Hcl	Memantine Hcl	81	16
Duloxetine Hcl	Duloxetine Hcl	79	14
Sertraline Hcl	Sertraline Hcl	76	22
Carvedilol	Carvedilol	70	12
Clopidogrel	Clopidogrel Bisulfate	68	11
Meloxicam	Meloxicam	67	16
Tramadol Hcl	Tramadol Hcl	65	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	64	38
Rosuvastatin Calcium	Rosuvastatin Calcium	64	15
Xarelto	Rivaroxaban	64	suppressed
Ezetimibe	Ezetimibe	56	suppressed
Buspirone Hcl	Buspirone Hcl	55	14
Jardiance	Empagliflozin	55	16
Oxybutynin Chloride Er	Oxybutynin Chloride	54	12
Alprazolam	Alprazolam	53	15
Prednisone	Prednisone	53	29
Nifedipine Er	Nifedipine	52	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	29
Megestrol Acetate	Megestrol Acetate	47	11
Pregabalin	Pregabalin	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Finasteride	Finasteride	45	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Risperidone	Risperidone	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	23
Allopurinol	Allopurinol	39	suppressed
Lorazepam	Lorazepam	39	13
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Eszopiclone	Eszopiclone	37	suppressed
Omeprazole	Omeprazole	35	suppressed
Atenolol	Atenolol	34	suppressed
Ondansetron Odt	Ondansetron	33	29
Doxycycline Hyclate	Doxycycline Hyclate	32	24
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Rivastigmine	Rivastigmine Tartrate	29	suppressed
Topiramate	Topiramate	29	suppressed
Methenamine Hippurate	Methenamine Hippurate	28	suppressed
Gemtesa	Vibegron	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	21
Levetiracetam	Levetiracetam	26	suppressed
Cephalexin	Cephalexin	25	19
Haloperidol	Haloperidol	24	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	17
Alendronate Sodium	Alendronate Sodium	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Nystatin	Nystatin	21	16
Verapamil Er	Verapamil Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Bethanechol Chloride	Bethanechol Chloride	19	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Digoxin	Digoxin	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Baclofen	Baclofen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Cefdinir	Cefdinir	16	12
Midodrine Hcl	Midodrine Hcl	16	suppressed
Trimethoprim	Trimethoprim	16	suppressed
Colesevelam Hcl	Colesevelam Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Folic Acid	Folic Acid	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Ramelteon	Ramelteon	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Azithromycin	Azithromycin	12	11
Metformin Er Gastric	Metformin Hcl	12	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	11	suppressed
Propafenone Hcl Er	Propafenone Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error